JOHN_ROSS_(CHEMISTS)_LIMI - Accounts

Company Registration No. SC209292 (Scotland)
JOHN ROSS (CHEMISTS) LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2019
PAGES FOR FILING WITH REGISTRAR
JOHN ROSS (CHEMISTS) LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 9
JOHN ROSS (CHEMISTS) LIMITED
BALANCE SHEET
AS AT
30 NOVEMBER 2019
30 November 2019
- 1 -
2019
2018
Notes
£
£
£
£
Fixed assets
Tangible assets
4
978,665
1,018,040
Investments
5
4,830
4,830
983,495
1,022,870
Current assets
Stocks
380,321
409,196
Debtors
6
1,395,530
1,271,918
Cash at bank and in hand
1,686
192,767
1,777,537
1,873,881
Creditors: amounts falling due within one year
7
(1,548,321)
(1,670,277)
Net current assets
229,216
203,604
Total assets less current liabilities
1,212,711
1,226,474
Creditors: amounts falling due after more than one year
8
(113,604)
(158,529)
Provisions for liabilities
(4,061)
(8,013)
Net assets
1,095,046
1,059,932
Capital and reserves
Called up share capital
100
100
Profit and loss reserves
1,094,946
1,059,832
Total equity
1,095,046
1,059,932

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 30 November 2019 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

JOHN ROSS (CHEMISTS) LIMITED
BALANCE SHEET (CONTINUED)
AS AT
30 NOVEMBER 2019
30 November 2019
- 2 -
The financial statements were approved by the board of directors and authorised for issue on 10 September 2020 and are signed on its behalf by:
J ROSS
Mr J Ross
Director
Company Registration No. SC209292
JOHN ROSS (CHEMISTS) LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2019
- 3 -
1
Accounting policies
Company information

John Ross (Chemists) Limited is a private company limited by shares incorporated in Scotland. The registered office is 12 - 16 Albyn Place, Aberdeen, Scotland, AB10 1PS.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

1.2
Going concern

The directors, having made due and careful enquiry, are of the opinion that the company has adequate working capital to execute its operations over the next 12 months. The directors, therefore, have made an informed judgement, at the time of approving the financial statements, that there is a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future.

 

In arriving at this conclusion, the directors have given due consideration to the impact of the worldwide Covid-19 pandemic on future operations and the ability of the company to continue to operate as a going concern. The directors recognise that the situation remains highly fluid and as a result making accurate forecasts on the likely implications is difficult but the directors do recognise that trading over the coming months could potentially be adversely affected. 

 

Despite this, the directors remain confident that the company can continue to operate as a going concern. This assessment is based on the understanding that the company will continue to trade over the coming months, albeit at a potentially reduced level from what was initially anticipated. This, along with government support measures that are available and the cash at bank will allow the company to continue to meet its obligations as they fall due and operate as a going concern.

 

As a result, the directors have continued to adopt the going concern basis of accounting in preparing the annual financial statements.

1.3
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

JOHN ROSS (CHEMISTS) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2019
1
Accounting policies
(Continued)
- 4 -
1.4
Intangible fixed assets - goodwill

Goodwill represents the excess of the cost of acquisition of unincorporated businesses over the fair value of net assets acquired. It is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is considered to have a finite useful life and is amortised on a systematic basis over its expected life, which is 10 years.

 

For the purposes of impairment testing, goodwill is allocated to the cash-generating units expected to benefit from the acquisition. Cash-generating units to which goodwill has been allocated are tested for impairment at least annually, or more frequently when there is an indication that the unit may be impaired. If the recoverable amount of the cash-generating unit is less than the carrying amount of the unit, the impairment loss is allocated first to reduce the carrying amount of any goodwill allocated to the unit and then to the other assets of the unit pro-rata on the basis of the carrying amount of each asset in the unit.

1.5
Intangible fixed assets other than goodwill

Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.

 

Intangible assets acquired on business combinations are recognised separately from goodwill at the acquisition date where it is probable that the expected future economic benefits that are attributable to the asset will flow to the entity and the fair value of the asset can be measured reliably.

Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Lease premium
Over 8 years
1.6
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Freehold property
2% Straight line
Improvements
2% Straight line
Fixtures and fittings
20% Straight line
Motor vehicles
25% Straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.7
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

JOHN ROSS (CHEMISTS) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2019
1
Accounting policies
(Continued)
- 5 -
1.8
Cash at bank and in hand

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.9
Financial instruments

The Company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors and loans from group companies. These are measured at amortised cost and are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the Statement of comprehensive income.

1.10
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.11
Retirement benefits

The company operates a defined contribution plan for it's employees. A defined contribution plan is a pension plan under which the company pays fixed contributions into a separate entity. Once the contributions have been paid the company has no further payment obligations. The contributions are recognised as an expense in the Statement of comprehensive income when they fall due. Amounts not paid are shown in accruals as a liability in the Balance sheet. The assets of the plan are held separately from the company in independently administered funds.

JOHN ROSS (CHEMISTS) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2019
1
Accounting policies
(Continued)
- 6 -
1.12
Leases

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.

 

Assets held under finance leases are recognised as assets at the lower of the assets fair value at the date of inception and the present value of the minimum lease payments. The related liability is included in the balance sheet as a finance lease obligation. Lease payments are treated as consisting of capital and interest elements. The interest is charged to profit or loss so as to produce a constant periodic rate of interest on the remaining balance of the liability.

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.

Rental income from operating leases is recognised on a straight line basis over the term of the relevant lease. Initial direct costs incurred in negotiating and arranging an operating lease are added to the carrying amount of the leased asset and recognised on a straight line basis over the lease term.

1.13
Government grants

Government grants are recognised at the fair value of the asset received or receivable when there is reasonable assurance that the grant conditions will be met and the grants will be received.

 

A grant that specifies performance conditions is recognised in income when the performance conditions are met. Where a grant does not specify performance conditions it is recognised in income when the proceeds are received or receivable. A grant received before the recognition criteria are satisfied is recognised as a liability.

1.14

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was 72 (2018 - 78).

JOHN ROSS (CHEMISTS) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2019
- 7 -
3
Intangible fixed assets
Goodwill
Lease premium
Total
£
£
£
Cost
At 1 December 2018 and 30 November 2019
2,721,055
103,889
2,824,944
Amortisation and impairment
At 1 December 2018 and 30 November 2019
2,721,055
103,889
2,824,944
Carrying amount
At 30 November 2019
-
-
-
At 30 November 2018
-
-
-
4
Tangible fixed assets
Freehold property
Improvements
Fixtures and fittings
Motor vehicles
Total
£
£
£
£
£
Cost
At 1 December 2018
891,638
206,985
751,667
167,065
2,017,355
Additions
6,225
-
2,781
15,248
24,254
At 30 November 2019
897,863
206,985
754,448
182,313
2,041,609
Depreciation and impairment
At 1 December 2018
144,776
40,476
713,309
100,754
999,315
Depreciation charged in the year
11,242
4,140
11,604
36,643
63,629
At 30 November 2019
156,018
44,616
724,913
137,397
1,062,944
Carrying amount
At 30 November 2019
741,845
162,369
29,535
44,916
978,665
At 30 November 2018
746,862
166,509
38,358
66,311
1,018,040
5
Fixed asset investments
2019
2018
£
£
Investments
4,830
4,830
JOHN ROSS (CHEMISTS) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2019
- 8 -
6
Debtors
2019
2018
Amounts falling due within one year:
£
£
Trade debtors
705,813
725,563
Other debtors
661,015
508,165
Prepayments and accrued income
28,702
38,190
1,395,530
1,271,918
7
Creditors: amounts falling due within one year
2019
2018
£
£
Bank loans and overdrafts
112,614
232,113
Obligations under finance leases
34,565
26,463
Trade creditors
1,175,690
1,128,755
Corporation tax
61,662
92,377
Other taxation and social security
29,714
29,813
Other creditors
2,165
1,815
Accruals and deferred income
131,911
158,941
1,548,321
1,670,277
8
Creditors: amounts falling due after more than one year
2019
2018
£
£
Bank loans and overdrafts
87,285
98,381
Other creditors
26,319
60,148
113,604
158,529

The loan is secured by a means of a fixed and floating charge over all assets of the company.

9
Operating lease commitments
Lessee

The total future lease payments under non-cancellable operating leases are as follows:

2019
2018
£
£
Within one year
7,583
7,583
Between two and five years
14,024
14,024
In over five years
82,183
89,766
103,790
111,373
JOHN ROSS (CHEMISTS) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2019
- 9 -
10
Related party transactions

Transactions

 

During the year the company advanced the director £277,260 and the director repaid £174,003 to the company. At the balance sheet date, the balance owed to the company was £273,938. (2018 - £170,681). The loan is unsecured and interest free with no fixed repayment terms in place.

 

During the year the company also operated a loan account with a company which is owned by the director. At the balance sheet date the company was owed £269,426 (2018 - £211,063).

 

During the year the company also operated a loan account with another company which is owned by the director. £710 was advanced during the year. At the balance sheet date, the balance owed to the company was £710.

2019-11-302018-12-01false10 September 2020CCH SoftwareCCH Accounts Production 2020.200No description of principal activityMr J RossMs C H HarroldSC2092922018-12-012019-11-30SC2092922019-11-30SC2092922018-11-30SC209292core:LandBuildingscore:OwnedOrFreeholdAssets2019-11-30SC209292core:LeaseholdImprovements2019-11-30SC209292core:FurnitureFittings2019-11-30SC209292core:MotorVehicles2019-11-30SC209292core:LandBuildingscore:OwnedOrFreeholdAssets2018-11-30SC209292core:LeaseholdImprovements2018-11-30SC209292core:FurnitureFittings2018-11-30SC209292core:MotorVehicles2018-11-30SC209292core:CurrentFinancialInstrumentscore:WithinOneYear2019-11-30SC209292core:CurrentFinancialInstrumentscore:WithinOneYear2018-11-30SC209292core:CurrentFinancialInstruments2019-11-30SC209292core:CurrentFinancialInstruments2018-11-30SC209292core:Non-currentFinancialInstruments2019-11-30SC209292core:Non-currentFinancialInstruments2018-11-30SC209292core:ShareCapital2019-11-30SC209292core:ShareCapital2018-11-30SC209292core:RetainedEarningsAccumulatedLosses2019-11-30SC209292core:RetainedEarningsAccumulatedLosses2018-11-30SC209292bus:Director12018-12-012019-11-30SC209292core:Goodwill2018-12-012019-11-30SC209292core:IntangibleAssetsOtherThanGoodwill2018-12-012019-11-30SC209292core:LandBuildingscore:OwnedOrFreeholdAssets2018-12-012019-11-30SC209292core:LeaseholdImprovementscore:LeasedAssetsHeldAsLessee2018-12-012019-11-30SC209292core:FurnitureFittings2018-12-012019-11-30SC209292core:MotorVehicles2018-12-012019-11-30SC2092922017-12-012018-11-30SC209292core:Goodwill2019-11-30SC209292core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill2019-11-30SC209292core:LandBuildingscore:OwnedOrFreeholdAssets2018-11-30SC209292core:LeaseholdImprovements2018-11-30SC209292core:FurnitureFittings2018-11-30SC209292core:MotorVehicles2018-11-30SC2092922018-11-30SC209292core:LeaseholdImprovements2018-12-012019-11-30SC209292core:WithinOneYear2019-11-30SC209292core:WithinOneYear2018-11-30SC209292core:BetweenTwoFiveYears2019-11-30SC209292core:BetweenTwoFiveYears2018-11-30SC209292core:MoreThanFiveYears2019-11-30SC209292core:MoreThanFiveYears2018-11-30SC209292bus:PrivateLimitedCompanyLtd2018-12-012019-11-30SC209292bus:SmallCompaniesRegimeForAccounts2018-12-012019-11-30SC209292bus:FRS1022018-12-012019-11-30SC209292bus:AuditExemptWithAccountantsReport2018-12-012019-11-30SC209292bus:Director22018-12-012019-11-30SC209292bus:FullAccounts2018-12-012019-11-30xbrli:purexbrli:sharesiso4217:GBP